278 related articles for article (PubMed ID: 18224408)
1. Mechanisms of transcriptional regulation by MLL and its disruption in acute leukemia.
Dou Y; Hess JL
Int J Hematol; 2008 Jan; 87(1):10-8. PubMed ID: 18224408
[TBL] [Abstract][Full Text] [Related]
2. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J
Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896
[TBL] [Abstract][Full Text] [Related]
3. Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications.
Milne TA; Martin ME; Brock HW; Slany RK; Hess JL
Cancer Res; 2005 Dec; 65(24):11367-74. PubMed ID: 16357144
[TBL] [Abstract][Full Text] [Related]
4. Expression of HOX genes in acute leukemia cell lines with and without MLL translocations.
Quentmeier H; Dirks WG; Macleod RA; Reinhardt J; Zaborski M; Drexler HG
Leuk Lymphoma; 2004 Mar; 45(3):567-74. PubMed ID: 15160920
[TBL] [Abstract][Full Text] [Related]
5. MLL is essential for NUP98-HOXA9-induced leukemia.
Shima Y; Yumoto M; Katsumoto T; Kitabayashi I
Leukemia; 2017 Oct; 31(10):2200-2210. PubMed ID: 28210005
[TBL] [Abstract][Full Text] [Related]
6. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential.
Wong P; Iwasaki M; Somervaille TC; So CW; Cleary ML
Genes Dev; 2007 Nov; 21(21):2762-74. PubMed ID: 17942707
[TBL] [Abstract][Full Text] [Related]
7. The miR-17∼92 cluster contributes to MLL leukemia through the repression of MEIS1 competitor PKNOX1.
Mian YA; Zeleznik-Le NJ
Leuk Res; 2016 Jul; 46():51-60. PubMed ID: 27123834
[TBL] [Abstract][Full Text] [Related]
8. The molecular biology of mixed lineage leukemia.
Slany RK
Haematologica; 2009 Jul; 94(7):984-93. PubMed ID: 19535349
[TBL] [Abstract][Full Text] [Related]
9. A role for MEIS1 in MLL-fusion gene leukemia.
Kumar AR; Li Q; Hudson WA; Chen W; Sam T; Yao Q; Lund EA; Wu B; Kowal BJ; Kersey JH
Blood; 2009 Feb; 113(8):1756-8. PubMed ID: 19109563
[TBL] [Abstract][Full Text] [Related]
10. The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis.
Muntean AG; Tan J; Sitwala K; Huang Y; Bronstein J; Connelly JA; Basrur V; Elenitoba-Johnson KS; Hess JL
Cancer Cell; 2010 Jun; 17(6):609-21. PubMed ID: 20541477
[TBL] [Abstract][Full Text] [Related]
11. Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9.
So CW; Karsunky H; Wong P; Weissman IL; Cleary ML
Blood; 2004 Apr; 103(8):3192-9. PubMed ID: 15070702
[TBL] [Abstract][Full Text] [Related]
12. DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis.
Nguyen AT; Taranova O; He J; Zhang Y
Blood; 2011 Jun; 117(25):6912-22. PubMed ID: 21521783
[TBL] [Abstract][Full Text] [Related]
13. Interaction of MLL amino terminal sequences with menin is required for transformation.
Caslini C; Yang Z; El-Osta M; Milne TA; Slany RK; Hess JL
Cancer Res; 2007 Aug; 67(15):7275-83. PubMed ID: 17671196
[TBL] [Abstract][Full Text] [Related]
14. Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias.
Mullighan CG; Kennedy A; Zhou X; Radtke I; Phillips LA; Shurtleff SA; Downing JR
Leukemia; 2007 Sep; 21(9):2000-9. PubMed ID: 17597811
[TBL] [Abstract][Full Text] [Related]
15. MEIS1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemia.
Roychoudhury J; Clark JP; Gracia-Maldonado G; Unnisa Z; Wunderlich M; Link KA; Dasgupta N; Aronow B; Huang G; Mulloy JC; Kumar AR
Blood; 2015 Apr; 125(16):2544-52. PubMed ID: 25740828
[TBL] [Abstract][Full Text] [Related]
16. Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia.
Jiang X; Huang H; Li Z; Li Y; Wang X; Gurbuxani S; Chen P; He C; You D; Zhang S; Wang J; Arnovitz S; Elkahloun A; Price C; Hong GM; Ren H; Kunjamma RB; Neilly MB; Matthews JM; Xu M; Larson RA; Le Beau MM; Slany RK; Liu PP; Lu J; Zhang J; He C; Chen J
Cancer Cell; 2012 Oct; 22(4):524-35. PubMed ID: 23079661
[TBL] [Abstract][Full Text] [Related]
17. Meis1 maintains stemness signature in MLL-AF9 leukemia.
Kumar AR; Sarver AL; Wu B; Kersey JH
Blood; 2010 Apr; 115(17):3642-3. PubMed ID: 20430967
[No Abstract] [Full Text] [Related]
18. MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia.
Monroe SC; Jo SY; Sanders DS; Basrur V; Elenitoba-Johnson KS; Slany RK; Hess JL
Exp Hematol; 2011 Jan; 39(1):77-86.e1-5. PubMed ID: 20854876
[TBL] [Abstract][Full Text] [Related]
19. Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.
Zeisig BB; Milne T; García-Cuéllar MP; Schreiner S; Martin ME; Fuchs U; Borkhardt A; Chanda SK; Walker J; Soden R; Hess JL; Slany RK
Mol Cell Biol; 2004 Jan; 24(2):617-28. PubMed ID: 14701735
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of homeobox genes MEIS1 and HOXA in MLL-rearranged acute leukemia impairs engraftment and reduces proliferation.
Orlovsky K; Kalinkovich A; Rozovskaia T; Shezen E; Itkin T; Alder H; Ozer HG; Carramusa L; Avigdor A; Volinia S; Buchberg A; Mazo A; Kollet O; Largman C; Croce CM; Nakamura T; Lapidot T; Canaani E
Proc Natl Acad Sci U S A; 2011 May; 108(19):7956-61. PubMed ID: 21518888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
